|
US3357956A
(en)
|
1965-03-30 |
1967-12-12 |
Du Pont |
Polymeric 1, 3, 4-thiadiazoles and the process for their preparation
|
|
CH482394A
(de)
|
1966-09-14 |
1969-12-15 |
Shell Int Research |
Herbizides Mittel
|
|
FR2097737A5
(en)
*
|
1970-07-14 |
1972-03-03 |
Berlin Chemie Veb |
Virustatic 4-substd 1-acylthiosemicarbazides -from carboxylic acid - hydrazide and isothiocyanates or from carboxylic acid chloride and 4-
|
|
DE2037257A1
(en)
|
1970-07-28 |
1972-02-03 |
Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt |
Poly-(5-amino-1,3,4-thiadiazol-2-yl) derivs prepn - intermediates for drug and polymer prodn
|
|
GB1336575A
(en)
|
1970-12-22 |
1973-11-07 |
Ilford Ltd |
Seleno-semicarbazides
|
|
GB1272920A
(en)
|
1971-03-15 |
1972-05-03 |
Berlin Chemie Veb |
New thiosemicarbazides
|
|
DE2348808C3
(de)
*
|
1973-09-28 |
1980-10-09 |
Hoechst Ag, 6000 Frankfurt |
Formmasse auf Poly(oxymethylen)-Basis
|
|
US4012360A
(en)
|
1973-12-03 |
1977-03-15 |
Ciba-Geigy Corporation |
Bis-salicyloyl-dicarboxylic acid dihydrazides as stabilizers for polyolefines
|
|
JPS5519847Y2
(enExample)
|
1973-12-20 |
1980-05-12 |
|
|
|
JPS583499B2
(ja)
|
1975-07-28 |
1983-01-21 |
旭化成株式会社 |
アンテイカサレタ ポリウレタンソセイブツ
|
|
US4258151A
(en)
|
1979-01-26 |
1981-03-24 |
Sloan-Kettering Institute For Cancer Research |
Pentapeptide modified resin
|
|
US4515954A
(en)
|
1981-08-24 |
1985-05-07 |
American Cyanamid Company |
Metal chelates of anthracene-9,10-bis-carbonylhydrazones
|
|
US4490080A
(en)
|
1983-02-18 |
1984-12-25 |
Precision Industries, Inc. |
Hole cutting tool
|
|
JPS59201047A
(ja)
*
|
1983-04-30 |
1984-11-14 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀写真要素
|
|
ATE72431T1
(de)
|
1985-08-31 |
1992-02-15 |
Fisons Plc |
5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren.
|
|
US4822777A
(en)
|
1987-02-27 |
1989-04-18 |
Liposome Technology, Inc. |
Amphotericin B/cholesterol sulfate composition
|
|
JP2767241B2
(ja)
|
1987-04-15 |
1998-06-18 |
ロ−ム アンド ハ−ス コンパニ− |
殺虫性のｎ−（場合により置換された）−ｎ′−置換−ｎ，ｎ′−ジ置換ヒドラジン
|
|
US4826866A
(en)
|
1987-11-02 |
1989-05-02 |
A. H. Robins Company, Incorporated |
3-amino-5-methyl-1H-pyrazole-4-carboxylic acids and esters thereof as anticonvulsants, muscle relaxants and anxiolytics
|
|
CA1340899C
(en)
|
1988-03-09 |
2000-02-15 |
Andre Bardy |
Procede de preparation de complexes nitruro 99m tc, 186 re ou 188 re utilisables comme produits radiopharmaceutiques
|
|
US6013836A
(en)
|
1992-02-28 |
2000-01-11 |
Rohm And Haas Company |
Insecticidal N'-substituted-N,N'-disubstitutedhydrazines
|
|
FR2697752B1
(fr)
|
1992-11-10 |
1995-04-14 |
Rhone Poulenc Rorer Sa |
Compositions antitumorales contenant des dérivés du taxane.
|
|
US5814658A
(en)
|
1992-12-09 |
1998-09-29 |
Rhone-Poulenc Rorer S.A. |
Taxoids, their preparation and pharmaceutical compositions containing them
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
NZ262679A
(en)
|
1993-02-22 |
1997-08-22 |
Vivorx Pharmaceuticals Inc |
Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US5665382A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US5840746A
(en)
|
1993-06-24 |
1998-11-24 |
Merck Frosst Canada, Inc. |
Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
|
|
US5523325A
(en)
|
1993-09-09 |
1996-06-04 |
Jacobson; Richard M. |
Amidrazones and their use as pesticides
|
|
EP0763014A1
(de)
|
1994-06-03 |
1997-03-19 |
Basf Aktiengesellschaft |
Carbamoylcarbonsäurehydrazide und ihre verwendung zur bekämpfung von schadpilzen
|
|
CA2166676C
(en)
|
1995-01-09 |
2007-05-01 |
Yasuhisa Fujibayashi |
Diagnostic agent for hypoxia or mitochondrial dysfunction comprising radioactive copper complex of dithiosemicarbazone derivative or diamine diol schiff base derivative
|
|
ATE184613T1
(de)
|
1995-09-22 |
1999-10-15 |
Novo Nordisk As |
Varianten des grünen fluoreszenzproteins, gfp
|
|
US5739686A
(en)
|
1996-04-30 |
1998-04-14 |
Naughton; Michael J. |
Electrically insulating cantilever magnetometer with mutually isolated and integrated thermometry, background elimination and null detection
|
|
JPH1031282A
(ja)
*
|
1996-05-17 |
1998-02-03 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
|
US5753200A
(en)
|
1996-10-07 |
1998-05-19 |
Solvay Minerals, Inc. |
Sodium metabisulfite process
|
|
US6235787B1
(en)
|
1997-06-30 |
2001-05-22 |
Hoffmann-La Roche Inc. |
Hydrazine derivatives
|
|
GB9727524D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Synergistic antitumor composition containing a biologically active ureido compound
|
|
US20030195268A1
(en)
|
1998-05-20 |
2003-10-16 |
Freitag James W. |
Novel foaming compositions and methods for making and using the composition
|
|
TW479053B
(en)
|
1998-10-19 |
2002-03-11 |
Agro Kanesho Co Ltd |
Hydrazineoxoacetamide derivatives and pesticides
|
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
|
US6670330B1
(en)
|
2000-05-01 |
2003-12-30 |
Theodore J. Lampidis |
Cancer chemotherapy with 2-deoxy-D-glucose
|
|
US6322303B1
(en)
|
2000-05-12 |
2001-11-27 |
David M. John |
Dunnage bag and method of making same
|
|
EP1164126A1
(de)
|
2000-06-16 |
2001-12-19 |
Basf Aktiengesellschaft |
Salicylsäurehydrazid-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung zur Bekämpfung von Schadpilzen
|
|
US6365745B1
(en)
|
2000-07-14 |
2002-04-02 |
Sumika Fine Chemicals Co., Ltd. |
Method for producing hydrazine derivative
|
|
EP1365796A2
(en)
|
2000-09-01 |
2003-12-03 |
Van Andel Institute |
Inhibition of mitogen-activated protein kinase (mapk) pathway: a selective therapeutic strategy against melanoma
|
|
US6656971B2
(en)
*
|
2001-01-25 |
2003-12-02 |
Guilford Pharmaceuticals Inc. |
Trisubstituted carbocyclic cyclophilin binding compounds and their use
|
|
TWI231211B
(en)
|
2001-05-01 |
2005-04-21 |
Abbott Lab |
Compositions and methods for enhancing the bioavailability of pharmaceutical agents
|
|
WO2002094259A1
(en)
|
2001-05-03 |
2002-11-28 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation
|
|
US6602907B1
(en)
|
2001-06-08 |
2003-08-05 |
University Of Central Florida |
Treatment of breast cancer
|
|
EP1405841B1
(en)
|
2001-06-20 |
2006-08-16 |
Kuraray Co., Ltd. |
Process for preparation of 2-oxocarboxylic acid esters
|
|
TWI332943B
(en)
|
2001-07-10 |
2010-11-11 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
|
TWI297335B
(en)
|
2001-07-10 |
2008-06-01 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
|
TWI252847B
(en)
*
|
2001-07-10 |
2006-04-11 |
Synta Pharmaceuticals Corp |
Synthesis of taxol enhancers
|
|
US6924312B2
(en)
*
|
2001-07-10 |
2005-08-02 |
Synta Pharmaceuticals Corp. |
Taxol enhancer compounds
|
|
MXPA02010231A
(es)
|
2001-11-27 |
2004-12-13 |
Warner Lambert Co |
Inhibidores aminotransferasa dependientes de aminoacidos de cadena ramificada y su uso en el tratamiento de las enfermedades neurodegenerativas.
|
|
NZ533397A
(en)
|
2001-11-28 |
2005-12-23 |
Sod Conseils Rech Applic |
5-sulphanyl-4H-1,2,4-triazole derivatives and their use as a medicament
|
|
TW200408407A
(en)
|
2001-11-30 |
2004-06-01 |
Dana Farber Cancer Inst Inc |
Methods and compositions for modulating the immune system and uses thereof
|
|
WO2003068054A2
(en)
|
2002-02-13 |
2003-08-21 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health Services |
Identification of ovarian cancer tumor markers and therapeutic targets
|
|
SG187991A1
(en)
|
2002-05-02 |
2013-03-28 |
Wyeth Corp |
Calicheamicin derivative-carrier conjugates
|
|
AU2003267071A1
(en)
|
2002-09-13 |
2004-04-30 |
Synta Pharmaceuticals Corp. |
Synthesis of indolizines
|
|
AU2006228035B2
(en)
|
2003-01-15 |
2010-02-18 |
Synta Pharmaceuticals Corp. |
Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer
|
|
TWI330079B
(en)
|
2003-01-15 |
2010-09-11 |
Synta Pharmaceuticals Corp |
Treatment for cancers
|
|
SI1611112T1
(sl)
|
2003-02-11 |
2012-12-31 |
Vernalis (R&D) Limited |
Izoksazolne spojine kot inhibitorji vroäśinskih ĺ ok proteinov
|
|
KR100575251B1
(ko)
|
2003-03-03 |
2006-05-02 |
재단법인서울대학교산학협력재단 |
ｐ38／ＪＴＶ－1을 유효성분으로 하는 암 치료용 약학적조성물 및 암 치료용 약학적 조성물의 스크리닝 방법
|
|
EP1493445A1
(en)
|
2003-07-04 |
2005-01-05 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibition of stress-induced ligand-dependent EGFR activation
|
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
|
WO2005035512A1
(ja)
|
2003-10-10 |
2005-04-21 |
Kyowa Hakko Kogyo Co., Ltd. |
チアジアゾリン誘導体
|
|
KR100544347B1
(ko)
|
2003-12-11 |
2006-01-23 |
한국생명공학연구원 |
디아릴이소옥사졸계 화합물을 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물
|
|
CA2560954A1
(en)
|
2004-03-26 |
2005-10-20 |
Amphora Discovery Corporation |
Certain triazole-based compounds, compositions, and uses thereof
|
|
JP2007532552A
(ja)
*
|
2004-04-06 |
2007-11-15 |
セマフォア ファーマシューティカルズ， インコーポレイテッド |
Ｐｔｅｎインヒビター
|
|
PL1781604T3
(pl)
|
2004-06-23 |
2014-01-31 |
Synta Pharmaceuticals Corp |
Sole bis(tiohydrazydoamidu) do leczenia nowotworów
|
|
WO2006010095A2
(en)
|
2004-07-09 |
2006-01-26 |
Elan Pharmaceuticals Inc. |
Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
|
|
WO2006033913A2
(en)
|
2004-09-16 |
2006-03-30 |
Synta Pharmaceuticals Corp. |
Bis (thio-hydrazide amides) for treament of hyperplasia
|
|
AU2005306471B2
(en)
|
2004-11-19 |
2009-12-17 |
Synta Pharmaceuticals Corp. |
Bis(thio-hydrazide amides) for increasing Hsp70 expression
|
|
WO2006062732A2
(en)
|
2004-11-19 |
2006-06-15 |
Synta Pharmaceuticals Corp. |
Compounds acting at the centrosome
|
|
MX2007009888A
(es)
|
2005-02-17 |
2007-10-16 |
Synta Pharmaceuticals Corp |
Compuestos para el tratamiento de trastornos proliferativos.
|
|
US20090042991A1
(en)
|
2005-04-15 |
2009-02-12 |
James Barsoum |
Methods of increasing natural killer cell activity for therapy
|
|
MX2007012688A
(es)
|
2005-04-15 |
2008-03-14 |
Synta Pharmaceuticals Corp |
Terapia de combinacion para el cancer con compuestos de bis(tiohidrazida) amida.
|
|
WO2006113493A2
(en)
|
2005-04-15 |
2006-10-26 |
Synta Pharmaceuticals Corp. |
Methods of determining cancer prognosis via natural killer cell activity
|
|
US7709683B2
(en)
|
2005-05-16 |
2010-05-04 |
Synta Pharmaceuticals Corp. |
Synthesis of bis(thio-hydrazide amide) salts
|
|
US7678832B2
(en)
|
2005-08-16 |
2010-03-16 |
Synta Pharmaceuticals Corp. |
Bis(thio-hydrazide amide) formulation
|
|
AR057976A1
(es)
*
|
2005-08-29 |
2008-01-09 |
Boehringer Ingelheim Int |
Biarilos sustituidos y su uso como medicamentos.
|
|
SI22254A
(sl)
|
2006-04-13 |
2007-10-31 |
Univerza V Ljubljani Fakulteta Za Farmacijo |
NOVI ARILSULFONOHIDRAZIDNI INHIBITORJI ENCIMOV MurC IN MurD
|
|
WO2007139955A2
(en)
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
WO2008024298A1
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceuticals Corp. |
Bis(thiohydrazide amides) for inhibiting angiogenesis
|
|
RU2475478C2
(ru)
|
2006-08-21 |
2013-02-20 |
Синта Фармасьютиклз Корп. |
Соединения для лечения пролиферативных расстройств
|
|
EP2063878A2
(en)
|
2006-08-21 |
2009-06-03 |
Synta Pharmaceuticals Corporation |
Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma
|
|
US8785451B2
(en)
|
2006-08-21 |
2014-07-22 |
Synta Pharmaceuticals Corp. |
Compounds for the treatment of proliferative disorders
|
|
AU2007288340A1
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceuticals Corp. |
Bis (thiohydrazide amides) for treating melanoma
|
|
US8497272B2
(en)
|
2006-08-21 |
2013-07-30 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
WO2008024299A2
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceuticals Corp. |
Combination with bis(thiohydrazide amides) for treating cancer
|
|
JP2010502616A
(ja)
|
2006-08-31 |
2010-01-28 |
シンタ ファーマシューティカルズ コーポレーション |
癌を治療するためのビス（チオヒドラジドアミド）の組み合わせ
|
|
US20080118562A1
(en)
|
2006-09-11 |
2008-05-22 |
Keizo Koya |
Bis(thiohydrazide amides) formulation
|
|
JP2010503674A
(ja)
|
2006-09-14 |
2010-02-04 |
シンタ ファーマシューティカルズ コーポレーション |
血管形成治療用化合物
|
|
WO2008033494A2
(en)
|
2006-09-15 |
2008-03-20 |
Synta Pharmaceuticals Corp. |
Purification of bis(thiohydrazide amides)
|
|
EP2096111A1
(en)
*
|
2006-11-20 |
2009-09-02 |
Japan Tobacco Inc. |
Pyrazoles and use thereof as drugs
|
|
US20090093538A1
(en)
|
2007-01-03 |
2009-04-09 |
Synta Pharmaceuticals Corp |
Method for treating cancer
|
|
US8093425B2
(en)
|
2007-04-30 |
2012-01-10 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
US8729111B2
(en)
|
2007-08-07 |
2014-05-20 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
WO2009064374A2
(en)
|
2007-11-09 |
2009-05-22 |
Synta Pharmaceuticals Corp. |
Oral formulations of bis(thiohydrazide amides)
|
|
US8637704B2
(en)
|
2007-11-28 |
2014-01-28 |
Synta Pharmaceuticals Corp. |
Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide)
|
|
TW200940050A
(en)
|
2007-11-28 |
2009-10-01 |
Synta Pharmaceuticals Corp |
Polymorphs of N-malonyl-bis(N'-methyl-N'-thiobenzoylhydrazide)
|
|
AU2008338594A1
(en)
|
2007-12-14 |
2009-06-25 |
Sciclone Pharmaceuticals, Inc. |
Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (HSAA)
|
|
US8581004B2
(en)
|
2008-02-21 |
2013-11-12 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
US8633323B2
(en)
|
2008-03-31 |
2014-01-21 |
Synta Pharmaceuticals Corp. |
Process for preparing bis(thiohydrazide amides)
|
|
CA2729757A1
(en)
|
2008-07-01 |
2010-01-07 |
The Johns Hopkins University |
Methods for treating neoplasia by inhibiting lactate dehydrogenase and/or nicotinamide phosphoribosyltransferase
|
|
MX2011004114A
(es)
|
2008-10-22 |
2011-08-15 |
Synta Pharmaceuticals Corp |
Complejos de metales de transicion de un compuesto bis (tiohidrazida amida).
|
|
NZ592400A
(en)
|
2008-10-22 |
2013-09-27 |
Synta Pharmaceuticals Corp |
Transition metal complexes of bis[thiohydrazide amide] compounds
|
|
EP2370402A2
(en)
|
2008-12-01 |
2011-10-05 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
WO2011069159A2
(en)
|
2009-12-04 |
2011-06-09 |
Synta Pharmaceuticals Corp. |
Bis[thiohydrazide amide] compounds for treating leukemia
|
|
US8815945B2
(en)
|
2010-04-20 |
2014-08-26 |
Masazumi Nagai |
Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers
|
|
TWI403871B
(zh)
|
2010-10-25 |
2013-08-01 |
Ind Tech Res Inst |
伺服馬達驅動之回授切換裝置及方法
|
|
JP2014534238A
(ja)
|
2011-11-10 |
2014-12-18 |
シンタ ファーマシューティカルズ コーポレーション |
癌を治療するためのビス（チオヒドラジドアミド）化合物の投与
|
|
US20130149392A1
(en)
|
2011-12-12 |
2013-06-13 |
Synta Pharmaceuticals Corp. |
Method of treating non-small cell lung cancer with bis-(thiohydrazide)amide compounds
|